Sanofi Aventis

URI: https://gptkb.org/entity/Sanofi_Aventis

GPTKB entity

Predicate	Object
gptkbp:instance_of	gptkb:Company
gptkbp:bfsLayer	3
gptkbp:bfsParent	gptkb:Sanofi
gptkbp:acquired	gptkb:Genzyme gptkb:Aventis
gptkbp:acquisition	gptkb:Amunix_Pharmaceuticals gptkb:Bioverativ gptkb:Kymab gptkb:Medi_Gene_AG Translate Bio
gptkbp:ceo	gptkb:Paul_Hudson
gptkbp:employees	around 100,000
gptkbp:founded	gptkb:2004
gptkbp:headquarters	gptkb:Paris,_France
https://www.w3.org/2000/01/rdf-schema#label	Sanofi Aventis
gptkbp:industry	gptkb:drug
gptkbp:key_people	gptkb:Paul_Hudson
gptkbp:market_cap	€100 billion (2021)
gptkbp:partnership	gptkb:GSK gptkb:temple gptkb:Boehringer_Ingelheim gptkb:Bristol-Myers_Squibb gptkb:Regeneron_Pharmaceuticals gptkb:Moderna gptkb:Regeneron
gptkbp:products	gptkb:Ambien gptkb:Dupixent gptkb:Company gptkb:Lantus gptkb:Cerdelga gptkb:Plavix gptkb:Aubagio gptkb:Praluent gptkb:Toujeo gptkb:Zaltrap gptkb:drug gptkb:Cablivi gptkb:Thymoglobulin antibiotics Allegra vaccines Eloxatin Lovenox Admelog Jevtana Sarclisa Xyzal
gptkbp:research_focus	gptkb:Company oncology rare diseases vaccines
gptkbp:revenue	€36.1 billion (2020)
gptkbp:stock_exchange	gptkb:Euronext_Paris
gptkbp:subsidiary	gptkb:Sanofi_Genzyme gptkb:Sanofi_Pasteur
gptkbp:type	gptkb:Company
gptkbp:website	www.sanofi.com